BioSpace News Archive

Biotech Beach

Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis

Parse Biosciences announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq).

October 26, 2022
·
2 min read
ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group

ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence (AI) by Everest Group, a leading global research firm focused exclusively on strategic IT, business process, and engineering services.

October 26, 2022
·
3 min read
Biotech Bay

Vistagen to Host Concordia Live Webinar on Mental Health with Leaders from McKinsey Health Institute, WEVO, and In KidZ

Vistagen today announced that the company’s Chief Executive Officer, Shawn Singh, will lead a Concordia Live Webinar on the need for innovative approaches to mental health treatment.

October 26, 2022
·
5 min read
BioMidwest

Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

Co-Diagnostics, Inc. announced that the Company will be hosting a booth this week at Africa Health/Medlab Africa in Johannesburg, South Africa on October 26-28, 2022.

October 26, 2022
·
1 min read
Drug Development

Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022

Cyclacel Pharmaceuticals, Inc. reported today preliminary dose escalation data from its ongoing 065-101 Phase 1/2 clinical study of oral fadraciclib, a cyclin dependent kinase (CDK) 2/9 inhibitor, for the treatment of patients with advanced solid tumors and lymphoma.

October 26, 2022
·
8 min read
Genetown

NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy “Game-Changing Breakthrough”

Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, is pleased to provide shareholders insight on a substantial industry development that is relevant to Innovation Pharmaceuticals’ investment in BT BeaMedical Technologies Ltd..

October 26, 2022
·
5 min read
Biotech Bay

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

Alterity Therapeutics today announced a poster presentation from the ongoing Biomarkers of Progression in Multiple System Atrophy natural history study was given at the 147th Annual Meeting of the American Neurological Association (ANA) on October 24, 2022.

October 26, 2022
·
5 min read
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November

Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15th to November 17th.

October 26, 2022
·
2 min read
Business

Ligand to Report Third Quarter Financial Results on November 7

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report third quarter 2022 financial results after the close of the U.S. financial markets on Monday, November 7, 2022 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.

October 26, 2022
·
2 min read
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA

Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced it has filed its ANDA Application with Paragraph IV Certification on July 20th, 2022 and received a Paragraph IV Acknowledgement Letter and Receipt from FDA on August 31st, 2022.

October 26, 2022
·
1 min read